Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för bepotastine besylate. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

11 träffar

Bibliografisk träff 2012-10-29

Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.2% ophthalmic solution evaluated by patient preference.

McCabe CF, McCabe SE.

Clin Ophthalmol · research-article; journal article · DOI 10.2147/opth.s35431

Bibliografisk träff 2012-09-10

Development of novel bepotastine salicylate salt bioequivalent to the commercial bepotastine besilate in beagle dogs.

Cho KH, Choi HG.

Drug Dev Ind Pharm · research support, non-u.s. gov't; journal article · DOI 10.3109/03639045.2012.717295

Bibliografisk träff 2012-05-01

Integrated phase III trials of bepotastine besilate ophthalmic solution 1.5% for ocular itching associated with allergic conjunctivitis.

Meier EJ, Torkildsen GL, Gow JA, McNamara TR, Gomes PJ, Williams JI, Bepotastine Besilate Ophthalmic Solutions Study Group.

Allergy Asthma Proc · clinical trial, phase iii; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.2500/aap.2012.33.3570

Bibliografisk träff 2011-10-31

Health-related quality of life assessed by the effect of bepotastine besilate in patients with pruritus: importance of emotions score in atopic dermatitis.

Kawakami T, Kimura S, Haga T, Doi R, Kyoya M, Nakagawa K, Soma Y.

J Dermatol · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1346-8138.2011.01418.x

Bibliografisk träff 2011-06-07

Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.

Williams JI, Kennedy KS, Gow JA, Torkildsen GL, Abelson MB, Gomes PJ, McNamara TR, Bepotastine Besilate Ophthalmic Solutions Study Group.

J Ocul Pharmacol Ther · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1089/jop.2011.0005

Bibliografisk träff 2011-02-15

Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis.

Wingard JB, Mah FS.

Clin Ophthalmol · review-article; journal article · DOI 10.2147/opth.s8665

Bibliografisk träff 2010-10-01

Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate.

Williams JI, Gow JA, Klier SM, McCue SL, Salapatek AM, McNamara TR.

Curr Med Res Opin · research support, non-u.s. gov't; review; evaluation study; journal article · DOI 10.1185/03007995.2010.486753

Bibliografisk träff 2010-07-01

Bepotastine besilate ophthalmic solution for the relief of nonocular symptoms provoked by conjunctival allergen challenge.

Torkildsen GL, Williams JI, Gow JA, Gomes PJ, Abelson MB, McNamara TR, Bepotastine Besilate Ophthalmic Solutions Clinical Study Group.

Ann Allergy Asthma Immunol · randomized controlled trial; journal article · DOI 10.1016/j.anai.2010.04.005

Bibliografisk träff 2010-05-20

Multicenter clinical evaluation of bepotastine besilate ophthalmic solutions 1.0% and 1.5% to treat allergic conjunctivitis.

Macejko TT, Bergmann MT, Williams JI, Gow JA, Gomes PJ, McNamara TR, Abelson MB, Bepotastine Besilate Ophthalmic Solutions Clinical Study Group.

Am J Ophthalmol · clinical trial, phase iii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.ajo.2010.02.007

Bibliografisk träff 2010-04-20

Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.

Kida T, Fujii A, Sakai O, Iemura M, Atsumi I, Wada T, Sakaki H.

Exp Eye Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.exer.2010.04.006

Bibliografisk träff 2009-06-21

Novel functional aspect of antihistamines: the impact of bepotastine besilate on substance p-induced events.

Kitaba S, Murota H, Yahata Y, Azukizawa H, Katayama I.

J Allergy (Cairo) · research-article; journal article · DOI 10.1155/2009/853687